In NASH, mitochondrial DNA (mtDNA) released from mitochondria can active NLRP3 in KCs.[31] He et al[32] found that suppressing NLRP3 in KCs can alleviate inflammatory and development of NASH. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.